Breaking
•Dow Jones Industrial Average Trades Near 52,500 After 1% Gain on Earnings as Futures Signal Further Strength - International Business Times Australia•Tech Billionaires and the New Struggle for Political Power - EU Today•U.S. Envoy Witkoff To Hold Peace Talks With Putin - newsradio 1040 who•Nooks swim glides past Azusa Pacific - Fairbanks Daily News-Miner•EdfaPay and GoPravo Launch SDPay to Expand Digital Payments in Sudan - TechAfrica News•Severely ill ICE detainees targeted for imminent deportation in Florida, advocates say•Africa CDC calls Ebola crisis summit as Nigeria records first case - Newsday•Foreign actors exploited Europe’s riots, did not start them - Euronews.com•Bangladesh Hindu Festival - Post Register•Timing to roll out US Army’s NGC2 depends on funds, commander says•A Deep Dive Into Double-Hit Lymphoma•Cost-of-living crisis? You wouldn’t know it by looking at these companies’ profits | Greg Jericho•Kagan says supreme court conservatives have made US political system ‘a nightmare’ - The Guardian•Majority of Australians who report penicillin allergy not truly allergic•Are we in danger of outsourcing all of childhood’s learning curves to AI?•Cancer campaigner Goodburn to deliver rugby match ball•Thousands of Greek students, teachers protest over education, pay - Reuters•Where India stands in Asian Para Games medal tally after 27-medal haul on Day 3•BREAKING: NY Congressional candidate released from IDF custody - KING5.com•First Emergency Air Transport Program for Canine Officers Takes Flight in Michigan | Newswise - Newswise•Dow Jones Industrial Average Trades Near 52,500 After 1% Gain on Earnings as Futures Signal Further Strength - International Business Times Australia•Tech Billionaires and the New Struggle for Political Power - EU Today•U.S. Envoy Witkoff To Hold Peace Talks With Putin - newsradio 1040 who•Nooks swim glides past Azusa Pacific - Fairbanks Daily News-Miner•EdfaPay and GoPravo Launch SDPay to Expand Digital Payments in Sudan - TechAfrica News•Severely ill ICE detainees targeted for imminent deportation in Florida, advocates say•Africa CDC calls Ebola crisis summit as Nigeria records first case - Newsday•Foreign actors exploited Europe’s riots, did not start them - Euronews.com•Bangladesh Hindu Festival - Post Register•Timing to roll out US Army’s NGC2 depends on funds, commander says•A Deep Dive Into Double-Hit Lymphoma•Cost-of-living crisis? You wouldn’t know it by looking at these companies’ profits | Greg Jericho•Kagan says supreme court conservatives have made US political system ‘a nightmare’ - The Guardian•Majority of Australians who report penicillin allergy not truly allergic•Are we in danger of outsourcing all of childhood’s learning curves to AI?•Cancer campaigner Goodburn to deliver rugby match ball•Thousands of Greek students, teachers protest over education, pay - Reuters•Where India stands in Asian Para Games medal tally after 27-medal haul on Day 3•BREAKING: NY Congressional candidate released from IDF custody - KING5.com•First Emergency Air Transport Program for Canine Officers Takes Flight in Michigan | Newswise - Newswise
TheNewsPulse.pro
Home/clinical trials/diseases/drugs
clinical_trials

STAT+: Pharmalittle: We’re reading about Mark Cuban eyeing rare disease drugs, a ketamine gold rush, and more

Confidence88·multiple reportsImportance90NP-EVT-20261021-D7FE96B

Mark Cuban has a new vision for his company Cost Plus Drugs: shake up the business of custom-made rare disease medicines

Read the original at the primary source
STAT+: Pharmalittle: We’re reading about Mark Cuban eyeing rare disease drugs, a ketamine gold rush, and more
Ed Silverman · 10/21/2026, 1:26:27 PM
Also on the network: airlinesairports · farmerspulse · foodpulse · indianhealthpulse · indias · keralahealth · naturepulse · travelerpulse

Discussion

ChatsPulse · 0 threads

No discussion yet. Sign in and start the first thread —